Terms: = Germ cell tumor AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
12 results:
1. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Ma K; Chen S; Chen X; Yang C; Yang J
World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
[TBL] [Abstract] [Full Text] [Related]
2. CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.
Ma K; Chen X; Liu W; Chen S; Yang C; Yang J
Sci Rep; 2022 Mar; 12(1):4295. PubMed ID: 35277559
[TBL] [Abstract] [Full Text] [Related]
3. lck expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
Ge L; Xu L; Lu S; Yan H
FEBS Open Bio; 2020 May; 10(5):904-911. PubMed ID: 32237064
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a lck targeted inhibitor.
Zepecki JP; Snyder KM; Moreno MM; Fajardo E; Fiser A; Ness J; Sarkar A; Toms SA; Tapinos N
Oncogene; 2019 Mar; 38(10):1734-1750. PubMed ID: 30353164
[TBL] [Abstract] [Full Text] [Related]
5. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
[TBL] [Abstract] [Full Text] [Related]
6. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.
Gump JM; Donson AM; Birks DK; Amani VM; Rao KK; Griesinger AM; Kleinschmidt-DeMasters BK; Johnston JM; Anderson RC; Rosenfeld A; Handler M; Gore L; Foreman N; Hankinson TC
Acta Neuropathol Commun; 2015 May; 3():30. PubMed ID: 25990246
[TBL] [Abstract] [Full Text] [Related]
7. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract] [Full Text] [Related]
8. The role of Src family kinases in growth and migration of glioma stem cells.
Han X; Zhang W; Yang X; Wheeler CG; Langford CP; Wu L; Filippova N; Friedman GK; Ding Q; Fathallah-Shaykh HM; Gillespie GY; Nabors LB
Int J Oncol; 2014 Jul; 45(1):302-10. PubMed ID: 24819299
[TBL] [Abstract] [Full Text] [Related]
9. Role of lymphocyte-specific protein tyrosine kinase (lck) in the expansion of glioma-initiating cells by fractionated radiation.
Kim RK; Yoon CH; Hyun KH; Lee H; An S; Park MJ; Kim MJ; Lee SJ
Biochem Biophys Res Commun; 2010 Nov; 402(4):631-6. PubMed ID: 20971076
[TBL] [Abstract] [Full Text] [Related]
10. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study].
Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D
Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
[TBL] [Abstract] [Full Text] [Related]
12. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.
Morford LA; Elliott LH; Carlson SL; Brooks WH; Roszman TL
J Immunol; 1997 Nov; 159(9):4415-25. PubMed ID: 9379040
[TBL] [Abstract] [Full Text] [Related]
